Point72 Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Hold
5,800
﹤0.01% 3174
2025
Q4
$432K Buy
+5,800
New +$424K ﹤0.01% 3313
2024
Q1
Sell
-3,500
Closed -$250K 2366
2023
Q4
$250K Buy
+3,500
New +$244K ﹤0.01% 1746
2023
Q1
Sell
-3,500
Closed -$262K 2371
2022
Q4
$262K Sell
3,500
-1,000
-22% -$71.2K ﹤0.01% 1230
2022
Q3
$290K Hold
4,500
﹤0.01% 1233
2022
Q2
$312K Buy
+4,500
New +$334K ﹤0.01% 1238

Other funds holding HOLX

Point72 Asset Management's HOLX Position: Q1 2026 in Review

Point72 Asset Management reduced its Hologic (HOLX) stake by 65% in Q1 2026, selling an estimated $10.2M and leaving 71,776 shares worth $5.43M. The position accounts for 0.01% of the portfolio, ranked #1650.

Point72 Asset Management first reported a position in HOLX in Q3 2015 and has held it in 28 quarters since. The position peaked at $132M in Q3 2023. 703 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Point72 Asset Management held 71,776 shares of Hologic worth $5.43M as of Q1 2026.
  • Point72 Asset Management sold 136,269 Hologic shares in Q1 2026, an estimated $10.2M.
  • Hologic made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1650 holding.
  • Point72 Asset Management first reported a position in Hologic in Q3 2015 and has held it in 28 quarters since.
  • Point72 Asset Management's Hologic position peaked at $132M in Q3 2023.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.